Surgery Partners Files 8-K
Ticker: SGRY · Form: 8-K · Filed: Dec 12, 2025 · CIK: 1638833
| Field | Detail |
|---|---|
| Company | Surgery Partners, Inc. (SGRY) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $425.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Surgery Partners filed an 8-K, but the details are in the exhibits.
AI Summary
On December 11, 2025, Surgery Partners, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no specific material events or financial details disclosed in the provided text. The report was filed as of December 12, 2025.
Why It Matters
This 8-K filing indicates that Surgery Partners, Inc. has submitted a report to the SEC, but the specific details of any material events or financial updates are not immediately available in this excerpt.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediate indication of significant positive or negative events.
Key Players & Entities
- Surgery Partners, Inc. (company) — Registrant
- 310 Seven Springs Way, Suite 500, Brentwood, TN 37027 (location) — Business Address
- December 11, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing?
The filing is primarily for "Other Events" and "Financial Statements and Exhibits" as of December 11, 2025.
What is the exact name of the company filing this report?
The exact name of the company is Surgery Partners, Inc.
When was the earliest event reported in this filing?
The earliest event reported was on December 11, 2025.
What is the principal executive office address for Surgery Partners, Inc.?
The address is 340 Seven Springs Way, Suite 600, Brentwood, Tennessee 37027.
What is the Commission File Number for Surgery Partners, Inc.?
The Commission File Number is 001-37576.
Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2025-12-11 18:51:12
Key Financial Figures
- $0.01 — h registered Common stock, par value $0.01 per share SGRY The Nasdaq Global Se
- $425.0 million — s, relating to the issuance and sale of $425.0 million in aggregate principal amount of the Is
Filing Documents
- tm2533288d1_8k.htm (8-K) — 25KB
- tm2533288d1_ex99-1.htm (EX-99.1) — 8KB
- tm2533288d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-25-120386.txt ( ) — 204KB
- sgry-20251211.xsd (EX-101.SCH) — 3KB
- sgry-20251211_lab.xml (EX-101.LAB) — 33KB
- sgry-20251211_pre.xml (EX-101.PRE) — 22KB
- tm2533288d1_8k_htm.xml (XML) — 4KB
01
Item 8.01 Other Events. On December 11, 2025, Surgery Center Holdings, Inc. (the "Issuer"), entered into a purchase agreement with Barclays Capital Inc. as representative of certain initial purchasers, relating to the issuance and sale of $425.0 million in aggregate principal amount of the Issuer's 7.250% senior unsecured notes due 2032 (the "Offering"). The net proceeds from the Offering will be used for general corporate purposes, including, but not limited to, repaying outstanding borrowings under its revolving credit facility. The consummation of the Offering is subject to market and other conditions. On December 11, 2025, Surgery Partners, Inc. issued a press release announcing the pricing of the notes offering. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated December 11, 202 5 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 12, 2025 SURGERY PARTNERS, INC. By: /s/ David T. Doherty David T. Doherty Executive Vice President and Chief Financial Officer